These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1719452)

  • 1. Centrally administered galanin inhibits osmotically stimulated arginine vasopressin release in conscious rats.
    Kondo K; Murase T; Otake K; Ito M; Oiso Y
    Neurosci Lett; 1991 Jul; 128(2):245-8. PubMed ID: 1719452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats.
    Sugimura Y; Murase T; Ishizaki S; Tachikawa K; Arima H; Miura Y; Usdin TB; Oiso Y
    Endocrinology; 2003 Jul; 144(7):2791-6. PubMed ID: 12810532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible involvement of endogenous opioid peptides in the inhibition of arginine vasopressin release by gamma-aminobutyric acid in conscious rats.
    Otake K; Kondo K; Oiso Y
    Neuroendocrinology; 1991 Aug; 54(2):170-4. PubMed ID: 1766553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats.
    Yokoi H; Arima H; Murase T; Kondo K; Iwasaki Y; Oiso Y
    Neurosci Lett; 1996 Sep; 216(1):65-7. PubMed ID: 8892393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin as a physiological neurotransmitter in hemodynamic control of arginine vasopressin release in rats.
    Kondo K; Murase T; Otake K; Ito M; Kurimoto F; Oiso Y
    Neuroendocrinology; 1993; 57(2):224-9. PubMed ID: 7685503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effects of centrally administered galanin on the hyperosmotically stimulated expression of vasopressin in the rat hypothalamus. An in situ hybridization and immunohistochemistry study.
    Landry M; Roche D; Calas A
    Neuroendocrinology; 1995 Apr; 61(4):393-404. PubMed ID: 7540263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vasopressin response to centrally administered hypertonic solutions in the conscious rat.
    Wells T; Forsling ML; Windle RJ
    J Physiol; 1990 Aug; 427():483-93. PubMed ID: 2120429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central administration of urocortin inhibits vasopressin release in conscious rats.
    Kakiya S; Yokoi H; Arima H; Iwasaki Y; Oki Y; Oiso Y
    Neurosci Lett; 1998 May; 248(2):144-6. PubMed ID: 9654364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory action of leumorphin on vasopressin secretion in conscious rats.
    Yamada T; Nakao K; Itoh H; Morii N; Shiono S; Sakamoto M; Sugawara A; Saito Y; Mukoyama M; Arai H
    Endocrinology; 1988 Mar; 122(3):985-90. PubMed ID: 3342763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
    Hogarty DC; Tran DN; Phillips MI
    Brain Res; 1994 Feb; 637(1-2):126-32. PubMed ID: 8180789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responses of vasopressin, atrial natriuretic peptide, and blood pressure to central osmotic stimulation.
    Iitake K; Kimura T; Ota K; Shoji M; Inoue M; Ohta M; Sato K; Yamamoto T; Yasujima M; Abe K
    Am J Physiol; 1989 Oct; 257(4 Pt 1):E611-6. PubMed ID: 2529777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous nociceptin in the regulation of arginine vasopressin release in conscious rats.
    Kakiya S; Murase T; Arima H; Yokoi H; Iwasaki Y; Miura Y; Oiso Y
    Endocrinology; 2000 Dec; 141(12):4466-71. PubMed ID: 11108256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanisms involved in growth hormone secretion induced by galanin in the rat.
    Murakami Y; Kato Y; Shimatsu A; Koshiyama H; Hattori N; Yanaihara N; Imura H
    Endocrinology; 1989 Mar; 124(3):1224-9. PubMed ID: 2465137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central effect of the enkephalin analogue FK-33824 on vasopressin secretion in conscious sheep.
    Wang XM; Tresham JJ; Congiu M; Scoggins BA; Coghlan JP
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):369-73. PubMed ID: 2929239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centrally administered neuropeptide FF inhibits arginine vasopressin release in conscious rats.
    Arima H; Murase T; Kondo K; Iwasaki Y; Oiso Y
    Endocrinology; 1996 May; 137(5):1523-9. PubMed ID: 8612481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central adiponectin functions to inhibit arginine vasopressin release in conscious rats.
    Iwama S; Sugimura Y; Murase T; Hiroi M; Goto M; Hayashi M; Arima H; Oiso Y
    J Neuroendocrinol; 2009 Sep; 21(9):753-9. PubMed ID: 19523167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats.
    Murase T; Kondo K; Otake K; Oiso Y
    Neuroendocrinology; 1993 Jun; 57(6):1092-6. PubMed ID: 7901784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naloxone reduces the feeding evoked by intracerebroventricular galanin injection.
    Dube MG; Horvath TL; Leranth C; Kalra PS; Kalra SP
    Physiol Behav; 1994 Oct; 56(4):811-3. PubMed ID: 7528433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the opioid kappa-receptor agonist U50488H on the secretion of arginine vasopressin. Study on the mechanism of U50488H-induced diuresis.
    Oiso Y; Iwasaki Y; Kondo K; Takatsuki K; Tomita A
    Neuroendocrinology; 1988 Dec; 48(6):658-62. PubMed ID: 3251164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.